Boston Trust Walden’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-347,250
Closed -$19.3M 379
2018
Q1
$19.3M Sell
347,250
-11,761
-3% -$645K 0.29% 107
2017
Q4
$19.2M Buy
359,011
+285,955
+391% +$13.5M 0.28% 113
2017
Q3
$3.15M Sell
73,056
-23,965
-25% -$1.14M 0.05% 250
2017
Q2
$5.86M Buy
97,021
+2,702
+3% +$160K 0.09% 213
2017
Q1
$6.54M Sell
94,319
-908
-1% -$63.1K 0.1% 209
2016
Q4
$6.35M Buy
95,227
+2,971
+3% +$193K 0.1% 207
2016
Q3
$6.11M Sell
92,256
-1,033
-1% -$70.7K 0.1% 206
2016
Q2
$6.76M Sell
93,289
-2,068
-2% -$142K 0.12% 200
2016
Q1
$6.16M Buy
95,357
+90
+0.1% +$5.97K 0.11% 205
2015
Q4
$6.83M Sell
95,267
-119
-0.1% -$8.8K 0.13% 199
2015
Q3
$7.32M Sell
95,386
-8,042
-8% -$649K 0.12% 209
2015
Q2
$7.67M Buy
103,428
+3,597
+4% +$259K 0.12% 202
2015
Q1
$7.24M Buy
99,831
+144
+0.1% +$10K 0.11% 198
2014
Q4
$6.59M Buy
99,687
+3,824
+4% +$233K 0.1% 202
2014
Q3
$5.25M Sell
95,863
-925
-1% -$52.5K 0.08% 205
2014
Q2
$5.63M Sell
96,788
-47,471
-33% -$2.79M 0.08% 198
2014
Q1
$8.94M Buy
144,259
+586
+0.4% +$34.1K 0.13% 183
2013
Q4
$7.67M Buy
143,673
+16,483
+13% +$885K 0.11% 188
2013
Q3
$6.38M Sell
127,190
-53,206
-29% -$2.6M 0.1% 191
2013
Q2
$8.26M Buy
+180,396
New +$8.07M 0.13% 177

Other funds holding MD

Boston Trust Walden's MD Position: Q2 2018 in Review

Boston Trust Walden sold out of Pediatrix Medical (MD) in Q2 2018, closing a stake of 347,250 shares — an estimated $19.3M sold.

Boston Trust Walden first reported a position in MD in Q2 2013 and held it in 20 quarters. The position peaked at $19.3M in Q1 2018. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.

  • Boston Trust Walden reported no remaining Pediatrix Medical position as of Q2 2018 after selling out during the quarter.
  • Boston Trust Walden sold 347,250 Pediatrix Medical shares in Q2 2018, an estimated $19.3M.
  • Boston Trust Walden first reported a position in Pediatrix Medical in Q2 2013 and held it in 20 quarters.
  • Boston Trust Walden's Pediatrix Medical position peaked at $19.3M in Q1 2018.
  • 322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.

Based on Boston Trust Walden's 13F filing for Q2 2018, filed 25 Jul 2018.